Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether BMS-817399 in combination with Methotrexate is
effective in treating moderate to severe rheumatoid arthritis.